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Adenoid cystic carcinoma of the Bartholin gland (BG-ACC) is a rare form of vulvar cancer. Literature reported 
approximately 350 cases of BG-ACC since 1864.   
Literature data and case reports suggested an aggressive nature with protracted clinical symptoms and a tendency 
for local recurrence despite adequate surgical excision with or without adjuvant radiotherapy.  
Survival rates of 71% and 59% are reported, respectively, at five and ten years.  
A comparative analysis of the immunohistochemical profile was performed with the homologous tumor of the 
salivary glands, and it was observed that the expression of various antigen in different morphological patterns of 
this neoplasia allowed some considerations about on its histogenesis that was hitherto never proposed. 
 






The primary carcinoma of the Bartholin gland 
(BG) is a rare female genital tumor, accounting 
for less than 1% of all malignant tumors of the 
female genital tract. The rare frequency and the 
difficult macroscopic diagnosis, during a clinical 
evaluation, make it a mysterious object, given its 
rarity (Crum et al. 2014). The scientific literature 
reports very few cases studied and published, 
even if the ACC-BG at early stage can be treated 
by wide local excision as a primary surgery (Khan 
and Abbasi 2020). Most commonly, generally 
ACC-BG has a propensity for perineural inva-
sion and is therefore associated with high local 
recurrence rates (Nieuwenhuyzen-de Boer et al. 
2020). The wide local excision and radical vul-
vectomy with or without lymph node dissection, 
are performed (Khan and Abbasi 2020). More 
long-term follow up is recommended to evaluate 
optimal primary treatment and roles of radio-
therapy and chemotherapy because ACC-BG re-
curs and metastasizes long after primary treat-
ment (Şahin Aker, Cansız Ersöz, and Ortaç 
2020). In our experience, authors report a case 
of adenoid cystic carcinoma of the Bartholin 
gland (BG-ACC) in their practice, discussing his-
topathology and its histogenesis. 
 
2. Case Report 
 
A 66-year-old woman, with no previous gyneco-
logical history, for about two years, presented a 
perineal painless swelling, corresponding with 
the posterior third of the left labium minus, con-
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sidered in a first time as a Bartholin cyst. The pa-
tient was scheduled for surgical marsupialization. 
During perineal surgery, a solitary solid and mo-
bile mass was noted in the BG, with lobulated 
margins of 30 x 27 mm, extending into subcuta-
neous and muscle tissue. An excisional biopsy 
was performed. The surgical sample was a nod-
ular formation of 30 x 20 mm, with pink color, 
with a granular and shiny surface, of sustained 
consistency. The specimen was fixed in formalin 
and in paraffin embedded.  
The sections stained with hematoxylin and eosin, 
and histochemical stains with PAS and Blu Al-
cian. The tissue was submitted to a panel of a 
several immunohistochemical antibodies: 
CKAE1/AE3, CK5/6, CK7, CK19, CK20, 
EMA, p63, SMACT, calponin, S-100, CD10, 
CD34, CD117, ER, PgR, mammaglobin, 
GCDFP-15, CEA, p53 and Ki67. The morpho-
logical finding of the lesion was detected as neo-
plastic. Lesion was largely represented by acinar 
structures of cribriform appearance, in which the 
holes were delimited by small, flattened cells 
(Figure 1a) and were occupied by a dense, weakly 
basophilic material (Figure 1b), PAS and Blue-
Alcian positive (Figures 4a, 4b). Solid, nodular-
looking cell agglomerates were scattered in mass 
samples. They consisted of small roundish, mon-
onuclear cells with poor cytoplasm and a hyper-
chromatic nucleus (Figures 1c, 1d, 2a). Some of 
these agglomerates had an entirely solid appear-
ance, while others showed a mixed aspect, in 
which the cribriform component was also repre-
sented in varying degrees. The latter started from 
the periphery of the nodule progressing, in a cen-
tripetal direction, until it was completely occu-
pied (Figures 2d, 3a). Neoplastic proliferation 
also occurred in the form of tubular structures, 
delimited by a monolayer cylinder-cubic epithe-
lium above a basal layer consisting of small-me-
dium roundish mononuclear elements. This 
component, however, was completely minor, ac-
counting for no more than 10% of the prolifer-
ation. It was also detected a diffuse perineural 
permeation and infiltration of periglandular 
structures (Figures 3b, 3c, 3d). The results of im-
munohistochemical research were in cribriform 
pattern (CKAE1/AE3 +, CK5/6 +, CK7 +, 
CK19 -/+, CK20 -, EMA +, CEA -, p63 +, 
SMACT +, S-100 + in neural structures, CD10 -
, CD34 -, CD117 -, ER -, PgR - , p53 -/+ and 
Ki67 >5%), in solid pattern (CKAE1/AE3 +, 
CK5/6 -, CK7 -, CK19 -, CK20 -, EMA -/+, 
CEA -, p63 +, SMACT +, S-100 -, CD10 -, 
CD34 -, CD117 - , ER -, PgR - , p53 -/+ and 
Ki67 >5%), and in tubular pattern 
(CKAE1/AE3 +, CK5/6 + luminal, CK7 +, 
CK19 + luminal, CK20 + luminal, EMA -, CEA 
+, p63 +, SMACT +, S-100 -, CD10 -, CD34 -, 
CD117 - , ER -, PgR - , p53 -/+ and Ki67 >5%).  
The diagnosis of BG-ACC tumor, involving sur-
gical margins with perineural invasion, was fi-
nally performed by pathologist. A radiological 
staging, by computer tomography (CT), scan-
ning chest, abdomen, and pelvis, revealed no 
metastatic evidence. Patient underwent radical 
local vulvectomy with bilateral inguinal lymph 
node dissection. Final diagnosis was a FIGO 
Stage 1b vulvar cancer. Patient completed six cy-
cles of adjuvant radiotherapy, 63 Gy/33 frac-
tions to her vulva using VMAT (Vaginal Sparing 
with Volumetric Modulated Arc Therapy), and 
she remained disease-free at 9 months (the short 




Figure 1. a) Acinar cribriform structure (HE); b) cribri con-
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Figure 2. a) Solid nodule, particular (HE); b) c) solid nodules 




Figure 3. a) Tubular structures (HE); b) c) d) Infiltration of 




Figure 4. a) PAS b) Blu-Alcian c) d) Keratin AE1-AE3, crib-




Figure 5 a) KAE1-AE3, floret-like cellular groups in a solid 
nodule; b) KAE1-AE3, tubular structures; c) d) K 5/6 in crib-




Figure 6. a) K 5/6 in tubular structures (luminal); b) c) d) K7 





Figure 7. a) K7 Tubular structures; b) c) d) K19 in a cribri-




Figure 8. a) EMA a cribriform acinus; b) c) in a solid nodule, 
floret-like-cellular groups d) tubular structures (luminal) 
 




Figure 9. a) b) c) P63 in a cribriform acinus, solid nodule, tub-




Figure 10. a) b) SMACT in a solid nodule and tubular struc-




Figure 11. a) CD117 in tubular structures (luminal) b) c) d) 
S100, nerve trunks permeated by neoplastic proliferation 
 
3. Discussion  
 
In a study of 2011 (Alsan et al. 2011), 79 cases of 
ACC were recorded in literature, with an inci-
dence of about 15% of all tumors of BG gland. 
Then, in a subsequent paper of 2017 (Di Donato 
et al. 2017), on 275 cases of primary tumors of 
BG 77 were ACC, with an incidence of about 
30%. In this investigation, tumors were classified 
by histotype: 80 squamous cell carcinoma 
(30.7%), 77 ACC (29.6%), 65 adenocarcinoma 
(25%), 7 transitional cell carcinoma (2.6%), 7 
sarcoma (2.6%), 3 neuroendocrine carcinoma 
(1.1%), 3 adenosquamous tumors (1.1%), 2 epi-
thelioid-myoepithelial carcinoma (0.7%), 16 rare 
tumors as others (6.1%). 
The ACC-BG accounts for only 0.30% of all fe-
male genital tract cancers, is considered as a rare 
malignancy and, therefore, worthy of further 
analysis and literature signaling. Like all BG ne-
oplasms, the ACC has no specific perineal char-
acteristics and is often clinically confused with 
the most frequent abscesses or cysts of the gland 
(Goh, McCully, and Wagner 2018). In the many 
literature reports, the most frequent sign during 
its perineal presentation was a vulvar mass in 147 
cases (53.5%). Nevertheless, despite its indolent 
course, it has a high rate of local recurrence and 
hematogenous metastatization, especially to the 
lungs. A typical characteristic of this neoplasm is 
the perineural penetration, explaining the high 
recurrence rate, even after complete tumor exci-
sion (Anaf et al. 1999).  
To better understand this rare neoplastic entity, 
it is opportune to discuss on the structure and 
immunohistochemical characteristics of Bartho-
lin gland. The Bartholin gland contains three 
types of epithelium. The glandular acini are lined 
by mucinous columnar epithelium, emerging in 
the ducts with a transitional epithelium and be-
coming squamous epithelium at the ostia open-
ing on the vestibule vaginalis. The different his-
tological types of tumors present in BG would 
be linked to the cell line from which it would 
take origin. Squamous carcinomas would origi-
nate from squamous orificial cells, transitional 
carcinomas from transitional cells of the excre-
tory duct, adenocarcinoma from acinar cells 
(Tsukahara et al. 1991).  
More complex, instead, the histogenesis of the 
ACC like that of morphologically similar tumors 
frequently arising in other locations, such as the 
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salivary glands, in the first line, followed by up-
per respiratory tract, nasopharynx, breast, uter-
ine cervix and brain (Tsukahara et al. 1991). 
Authors hypothesized that such neoplasms may 
originate from the reserve cells present in the in-
tercalated small ducts of Bartholin gland that 
may have the potential to differentiate into two 
cell types, myoepithelial and luminal cells. As al-
ready recorded by other authors, as in our case, 
this histotype presents three morphological var-
iously intermingled patterns: 1) one acinar crib-
riform (Figure 1a, 1b, 1c, 1d); 2) one solid, con-
sisting of small mononuclear cells with a poor 
cytoplasmic halo (Figures 2a, 2b, 2c, 2d); 3) an-
other tubular, consisting of luminal cubic cylin-
der elements below, which a layer of basal cells 
of small volume is present (Figures 3a, 3b, 3c, 
3d) (Tsukahara et al. 1991). 
In the mentioned case, the three patterns are ir-
regularly mixed, with a clear prevalence of that 
acinar/cribriform, so authors separately evalu-
ated the immunohistochemical profile of the 
three patterns:  
a) the acinar / cribriform pattern presented pos-
itivity for almost all the cytokeratins tested, even 
with varying intensities and distribution. 
CKAE1/AE3 intense and diffuse (Figures 4a, 
4b, 4c, 4d), CK5/6 expressed by the cells located 
in the nodal points of the cribriform (Figure 5c), 
Ki67 intense and diffuse (Figure 6b), CK19 pre-
sented only in some acini in marginal place (Fig-
ure 7b) and EMA expressed in single elements 
in the nodal points of the cribri (Figure 8a), pos-
itive p63 (Figure 9a) and SMACT (Figure 9d), 
negatives S100, CD34, CD117, CEA, ER, PGR, 
p53, Ki67 <5%;  
b) the solid pattern presented positivity for 
CKAE/AE3 (Figure 4d), p63 (Figure 9b) and 
SMACT (Figure 10a). Concerning to the nod-
ules, scattered groups of larger elements in a flo-
ret-like arrangement were noticed, expressing cy-
tokeratin more intensely (Figure 5a) and, addi-
tionally, these elements expressed EMA (Figures 
8b, 8c). Transitional aspects were present in sig-
nificant number, wherein the formation of the 
cribriform begins from the periphery of the nod-
ules up to completely replace the solid compo-
nent, with a subsequent expression of the differ-
ent types of cytokeratin (Figure 6d).  
c) the tubular pattern, the less represented in the 
proliferation, expressed almost all cytokeratins, 
except for CK20, with a diffuse character, the 
CKAE1-AE3 (Figure 5b) and 7 (Figure 7a), the 
5/6 (luminal) (Figure 6a) and CK19 (luminal) 
(Figure 7d), EMA (luminal) (Figure 8d), p63 
(Figure 8c) and SMACT (Figure 10b) (basal). In 
a similar vein, CD117 (luminal) was also positive 
(Figure 11a), S100 was positive only in the nerv-
ous trunks infiltrated by the neoplasm (Figures 
11b, 11c, 11d).         
An article on the BG tumors, reported for the 
ACC the following immunohistochemical pro-
file: CKAE1/AE3 +, CK8/18 +, SMA +, SMM 
+, p63 +, S-100 + and EMA + (Goh, McCully, 
and Wagner 2018).  
Overall, the immunophenotypic profile of our 
case is in line with the data reported in the liter-
ature. The expression of many antigens in differ-
ent morphological patterns allowed us some his-
togenetic considerations hitherto never ad-
vanced. The "primum movens" would be identi-
fied in the solid nodules generated by the prolif-
eration of elements with a morphologic and im-
munophenotypic myoepithelial profile. From 
the periphery of these nodules begins the mor-
phological and immunohistochemical epithelial 
differentiation that leads to the formation of the 
cribriform acinar structures and to the tubular 
ones. In the above-mentioned case, there are ev-
idence of the nerve structures permeation phe-
nomena in surrounding tissues, that made the 
neoplasms prognosis very severe, as several 




The primary ACC-BG is a rare vulval cancer, 
characterized by slow growth, local invasion, 
and sometimes distant metastasis. Available lit-
erature suggests an aggressive nature with pro-
tracted clinical symptoms and local recurrence 
despite adequate surgical excision with or with-
out adjuvant radiotherapy. Local recurrences 
are common and often precede distant metasta-
ses (Yoon et al. 2015). The recommended pri-
mary treatment is vulvectomy, obtaining clear 
margins and bilateral inguinofemoral node dis-
section. Despite being diagnosed at a more ad-
vanced stage, patients with primary carcinoma 
of the Bartholin gland seem to have similar on-
cologic outcomes and survival rates to patients 
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with non-Bartholin gland-related vulvar carci-
noma (Zhan et al. 2014). 
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